The Truth behind the GLP-1
weight loss Medication
⚡ LIMITED SPOTS THIS MONTH — Only few seats remaining for July
R
P
A
Doctor-Led Metabolic Health Program — Built for India
Stop Fighting Your Body. Science Will Do It For You.
Doctor-led care, AI-guided tracking, and prescription medications dispensed only after a qualified consultation — built around how India actually eats.
Care, considered
Average -20% body weight in 4 months
5,300+
Members
30+
Doctors on Care Team
4.8★
Member Rating
The real problem
Metabolic health is biology,
not willpower.
Over 205 million Indians live with obesity. Urban professionals face a difficult combination — sedentary work, stress, irregular sleep, and metabolic adaptation. Standard diets rarely address the underlying clinical picture.
Hunger and satiety hormones can drive overeating
Sustained calorie restriction can slow metabolism
Clinical, supervised care tends to outperform another diet app
The approach
A three-step clinical pathway
01
Medical assessment
Qualified clinicians review the metabolic profile and recommend a care plan. Where appropriate and only after consultation, GLP-1 medications may be prescribed and delivered to the doorstep.
02
AI-guided tracking
The MetaFit app helps log meals, movement, and sleep. The care team uses these signals to adjust the plan with the member.
03
Ongoing care team
A dedicated doctor, nutritionist, and coach stay in regular contact — real clinicians, not chatbots.
Our medical team
Board-certified clinicians experienced in metabolic care.
MBBS, MD — endocrinology, internal medicine, clinical nutrition
As Seen In
The science the world is talking about
The Truth behind the GLP-1
INDIA TODAY
News / Health / Dr . Ambrish Mithal on the happy side - effects of weight loss drugs
Endocrinologist Dr. Ambrish Mithal on the happy side‑effects of weight loss drugs
New GLP-1 Weight-loss drugs are changing obesity treatment in India with promising health benefits. The leading medication of the weight loss revolution.
India's Top Endocrinologist Dr. Ambrish Mithal
World Health
Organization
Home / News / WHO issues global guideline on the use of GLP-1 medicines in treating obesity
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
1 December 2025 | News release | Reading time: 3 min (823 words)
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its first guideline on the use of Glucagon‑Like Peptide‑1 (GLP‑1) therapies for treating obesity as a chronic, relapsing disease.
WHO Approved GLP-1 medicines in treating obesity
View full Report
Member voices
“The weekly doctor check-ins and AI food tracking changed how I think about every meal. I finally feel in control of my health.”
R
Rahul S.
Bengaluru · MetaFit member
“As a busy professional, the doorstep medication and care team meant I never had to choose between my work and my health.”
P
Priya M.
Mumbai · MetaFit member
All members shown have consented to appear on this page. Individual experiences vary.
4-month program
MetaFit Care Program
₹5,999/ month
- Consultation with a qualified clinician
- AI-guided tracking app and lifestyle coaching
- At-home diagnostics and doorstep medication where prescribed
- Dedicated doctor, nutritionist, and coach
- Ongoing care team check-ins through the program
100% confidential · Free consultation first
DCGI-compliant · Prescription medications dispensed only after a qualified medical consultation. Individual results vary.
Book a free consultation
Free consultation • No commitment required